Nucala 100mg (Mepolizumab Vials) 100mg

NUCALA 100MG (Mepolizumab) is a prescription medication in vial form, used for severe eosinophilic conditions. It belongs to a class of biologics targeting specific immune pathways. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using this therapy.

Strength

100mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

GlaxoSmithKline Manufacturing S.P.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mepolizumab 100mg is used to treat severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. It helps reduce flare-ups and maintain control in patients with elevated eosinophils. The medication is also prescribed for hypereosinophilic syndrome when standard treatments are insufficient. Healthcare professionals determine suitability based on clinical evaluation.

Side Effects

Many patients report improved breathing and fewer asthma attacks after starting Mepolizumab. Some experience reduced fatigue and better daily function due to fewer disease flare-ups. Headache and injection-site reactions are among the commonly reported effects. Individual responses may vary based on condition severity and treatment history.

Precautions & Warnings

Keep NUCALA 100MG refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Discuss any active infections with your healthcare provider before starting treatment. Monitor for signs of allergic reactions, especially after the first few doses. Always use as directed by a medical professional.

Avoid Interactions

Certain vaccines and other biologics may interact with Mepolizumab, so inform your provider about all medications. Avoid live vaccines during treatment unless approved by your doctor. Some immunosuppressants could increase infection risk when combined with this therapy. Alcohol use should be discussed with a healthcare provider before starting this medication.

References

Frequently Asked Questions

NUCALA 100MG is used to treat severe eosinophilic asthma and related eosinophilic conditions.

Mepolizumab 100mg is given as an injection under medical supervision, typically every 4 weeks.

NUCALA 100MG is available by prescription only; consult your healthcare provider for ordering options.

Common side effects may include headache, injection-site reactions, and back pain.

No, NUCALA 100MG is a biologic therapy and not a corticosteroid.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.